126 related articles for article (PubMed ID: 32669078)
1. Enterovirus D-68 Molecular Virology, Epidemiology, and Treatment: an Update and Way Forward.
Ebada MA; Fayed N; Alkanj S; Allah AW
Infect Disord Drug Targets; 2021; 21(3):320-327. PubMed ID: 32669078
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features of Acute Flaccid Myelitis Temporally Associated With an Enterovirus D68 Outbreak: Results of a Nationwide Survey of Acute Flaccid Paralysis in Japan, August-December 2015.
Chong PF; Kira R; Mori H; Okumura A; Torisu H; Yasumoto S; Shimizu H; Fujimoto T; Hanaoka N; Kusunoki S; Takahashi T; Oishi K; Tanaka-Taya K;
Clin Infect Dis; 2018 Feb; 66(5):653-664. PubMed ID: 29028962
[TBL] [Abstract][Full Text] [Related]
3. Trends of Enterovirus D68 Concentrations in Wastewater, California, USA, February 2021-April 2023.
Boehm AB; Wadford DA; Hughes B; Duong D; Chen A; Padilla T; Wright C; Moua L; Bullick T; Salas M; Morales C; White BJ; Glaser CA; Vugia DJ; Yu AT; Wolfe MK
Emerg Infect Dis; 2023 Nov; 29(11):2362-2365. PubMed ID: 37877593
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus D68 molecular and cellular biology and pathogenesis.
Elrick MJ; Pekosz A; Duggal P
J Biol Chem; 2021; 296():100317. PubMed ID: 33484714
[TBL] [Abstract][Full Text] [Related]
5. RNA Structure in the 5' Untranslated Region of Enterovirus D68 Strains with Differing Neurovirulence Phenotypes.
Eastman C; Tapprich WE
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851509
[TBL] [Abstract][Full Text] [Related]
6. Understanding Enterovirus D68-Induced Neurologic Disease: A Basic Science Review.
Hixon AM; Frost J; Rudy MJ; Messacar K; Clarke P; Tyler KL
Viruses; 2019 Sep; 11(9):. PubMed ID: 31487952
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus D68 Infection in Human Primary Airway and Brain Organoids: No Additional Role for Heparan Sulfate Binding for Neurotropism.
Sridhar A; Depla JA; Mulder LA; Karelehto E; Brouwer L; Kruiswijk L; Vieira de Sá R; Meijer A; Evers MM; van Kuppeveld FJM; Pajkrt D; Wolthers KC
Microbiol Spectr; 2022 Oct; 10(5):e0169422. PubMed ID: 36154279
[TBL] [Abstract][Full Text] [Related]
8. Duration of Enterovirus D68 RNA Shedding in the Upper Respiratory Tract and Transmission among Household Contacts, Colorado, USA.
Nguyen-Tran H; Thompson C; Butler M; Miller KR; Pyle L; Jung S; Rogers S; Ng TFF; Routh J; Dominguez SR; Messacar K
Emerg Infect Dis; 2023 Nov; 29(11):2315-2324. PubMed ID: 37877582
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Characterization of the Mechanism of Action of
Ma C; Hu Y; Zhang J; Wang J
ACS Infect Dis; 2020 Aug; 6(8):2260-2270. PubMed ID: 32692536
[TBL] [Abstract][Full Text] [Related]
10. Predicting the impact of COVID-19 non-pharmaceutical intervention on short- and medium-term dynamics of enterovirus D68 in the US.
Park SW; Messacar K; Douek DC; Spaulding AB; Metcalf CJE; Grenfell BT
Epidemics; 2024 Mar; 46():100736. PubMed ID: 38118274
[TBL] [Abstract][Full Text] [Related]
11. Telaprevir Treatment Reduces Paralysis in a Mouse Model of Enterovirus D68 Acute Flaccid Myelitis.
Frost J; Rudy MJ; Leser JS; Tan H; Hu Y; Wang J; Clarke P; Tyler KL
J Virol; 2023 May; 97(5):e0015623. PubMed ID: 37154751
[TBL] [Abstract][Full Text] [Related]
12. Multimodal Surveillance Model for Enterovirus D68 Respiratory Disease and Acute Flaccid Myelitis among Children in Colorado, USA, 2022.
Messacar K; Matzinger S; Berg K; Weisbeck K; Butler M; Pysnack N; Nguyen-Tran H; Davizon ES; Bankers L; Jung SA; Birkholz M; Wheeler A; Dominguez SR
Emerg Infect Dis; 2024 Mar; 30(3):423-431. PubMed ID: 38407198
[TBL] [Abstract][Full Text] [Related]
13. Detection of enterovirus D68 among children with severe acute respiratory infection in Myanmar.
Ikuse T; Aizawa Y; Kachikawa R; Kamata K; Osada H; Win SMK; Di Ja L; Win NC; Thein KN; Thida A; Tun A; Ito A; Kyaw Y; Tin HH; Shobugawa Y; Watanabe H; Saito R; Saitoh A
J Microbiol Immunol Infect; 2024 Apr; 57(2):238-245. PubMed ID: 38233293
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology and recombination of enterovirus D68 in China.
Shi Y; Liu Y; Wu Y; Hu S; Sun B
Infect Genet Evol; 2023 Nov; 115():105512. PubMed ID: 37827347
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characteristics of the 2022 Enterovirus-D68 outbreak among hospitalized children, Ohio, USA.
Cao RG; Mejias A; Leber AL; Wang H
J Clin Virol; 2023 Dec; 169():105618. PubMed ID: 37977074
[TBL] [Abstract][Full Text] [Related]
16. A novel mucosal bivalent vaccine of EV-A71/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge.
Lin YL; Cheng PY; Chin CL; Chuang KT; Lin JY; Chang N; Pan CK; Lin CS; Pan SC; Chiang BL
J Biomed Sci; 2023 Dec; 30(1):96. PubMed ID: 38110940
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo models for the study of EV-D68 infection.
Hooi YT; Balasubramaniam VRMT
Pathology; 2023 Dec; 55(7):907-916. PubMed ID: 37852802
[TBL] [Abstract][Full Text] [Related]
18. Insights into the molecular evolution of enterovirus D68.
Wolf J
Arch Virol; 2023 Oct; 168(11):268. PubMed ID: 37804367
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular epidemiology of enterovirus D68 from 2013 to 2020 in Shanghai.
Li F; Lu RJ; Zhang YH; Shi P; Ao YY; Cao LF; Zhang YL; Tan WJ; Shen J
Sci Rep; 2024 Jan; 14(1):2161. PubMed ID: 38272942
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional seroepidemiology study of EV-D68 in China.
Sun S; Gao F; Hu Y; Bian L; Wu X; Su Y; Du R; Fu Y; Zhu F; Mao Q; Liang Z
Emerg Microbes Infect; 2018 Jun; 7(1):99. PubMed ID: 29872035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
